ceritinib has been researched along with Spinal-Cord-Neoplasms* in 2 studies
2 other study(ies) available for ceritinib and Spinal-Cord-Neoplasms
Article | Year |
---|---|
Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors.
Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Crizotinib; Female; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Meningeal Neoplasms; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Spinal Cord Neoplasms; Sulfones; Treatment Outcome | 2019 |
ALK-rearranged lung cancer with intradural extramedullary spinal cord metastases responding to ceritinib treatment: A case report.
Intradural extramedullary spinal cord metastases in lung cancer are rarely reported, but are a disastrous event because of severe clinical symptoms and poor prognosis. Herein, we report a case of a lung cancer patient with ALK rearrangement who experienced brain, leptomeningeal, and intradural extramedullary spinal cord metastases after developing resistance to crizotinib. After ceritinib therapy, his clinical symptoms improved and magnetic resonance imaging revealed that the intradural extramedullary lesions had reduced. Topics: Anaplastic Lymphoma Kinase; China; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Spinal Cord Neoplasms; Sulfones; Translocation, Genetic; Treatment Outcome | 2018 |